PharmaCorp Rx Inc. operates retail pharmacies in Canada, providing prescription drugs and specialized compounding services. Key strengths include a strong liquidity position with a current ratio of 9.42 and a solid gross margin of 38.8%. However, concerns arise from low profitability metrics, with a net margin of only 1.5% and minimal returns on equity and assets. The high liquidity contrasts with the low valuation, indicating potential inefficiencies or challenges in converting sales into profits. Overall, while the company shows financial stability, its profitability remains a significant concern.
Loading financial metrics...
No significant red flags identified
This company appears financially healthy on available metrics
Exceptional revenue growth of 153.2% YoY demonstrates strong market demand and competitive positioning.
Fortress balance sheet: cash covers total debt 5.2×, providing significant financial flexibility.
Excellent liquidity with current ratio of 9.4x ensures operational stability.
Low debt-to-revenue ratio of 18.6% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Pharmaceutical Retailers companies of a similar size
Based on 2026-Q1 (March 31, 2026)